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Background: Williams-Beuren Syndrome (WBS) is caused by the microdeletion of approximately 25 genes on
chromosome 7q11.23, and is characterized by a spectrum of cognitive and behavioural features.
Results: We generated cortical neurons from a WBS individual and unaffected (WT) control by directed differentiation of
induced pluripotent stem cells (iPSCs). Single cell mRNA analyses and immunostaining demonstrated very efficient
production of differentiated cells expressing markers of mature neurons of mixed subtypes and from multiple cortical
layers. We found that there was a profound alteration in action potentials, with significantly prolonged WBS repolarization
times and a WBS deficit in voltage-activated K+ currents. Miniature excitatory synaptic currents were normal, indicating
that unitary excitatory synaptic transmission was not altered. Gene expression profiling identified 136 negatively enriched
gene sets in WBS compared to WT neurons including gene sets involved in neurotransmitter receptor activity, synaptic
assembly, and potassium channel complexes.
Conclusions: Our findings provide insight into gene dysregulation and electrophysiological defects in WBS patient neurons.
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Williams-Beuren Syndrome (WBS; OMIM #194050) is a
rare neurodevelopmental disorder caused by the hemizygous
deletion of a cluster of ~25 protein coding genes at 7q11.23.
It is characterized by cardiac abnormalities, including supra-
valvular aortic stenosis, infantile hypercalcemia, characteris-
tic facial features and a unique constellation of cognitive and
behavioural impairments [1, 2]. Specifically, individuals with
WBS have relatively preserved expressive language skills,
but extreme weakness in visuospatial construction along-
side over-friendliness, social disinhibition, and a high
prevalence of anxiety-related disorders [3, 4]. This syn-
drome provides a unique opportunity to study the* Correspondence: jellis@sickkids.ca
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phenotypes in relation to a well characterized genetic le-
sion. Thus far, functional and structural imaging studies
have implicated specific brain regions in altered visuo-
spatial processing [5] and facial recognition [6], but, how
the deleted genes contribute to this altered function, or to
the development of more common psychiatric features as-
sociated with WBS remains unclear.
Both animal model and human studies have been used
to attempt to understand the molecular basis for the
WBS neurological features, but both approaches have
inherent limitations. Animal models have offered critical
insight into the cellular and molecular bases of in vivo
phenotypes [7], but in a non-human context, and so
require validation in relevant human cells. The study of
human tissue samples has explored the effect of 7q11.23
dosage on human-specific gene networks, but in cell
populations that are unrelated to brain development and
function [8, 9].is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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able human tissues, we differentiated WBS patient-specific
induced pluripotent stem cells (iPSC) into cortical neurons
for modeling the neuronal phenotype of WBS. Our ana-
lyses suggest that all layers of the cerebral cortex were rep-
resented by our population of iPSC derived neurons and
the cells behaved like traditionally derived neurons, indi-
cating successful differentiation. WBS-derived neurons
showed altered action potential repolarization times
when compared to control neurons, as determined
through electrophysiology analysis, suggesting a defect
in potassium channel conductance. We also examined
gene expression and identified differentially expressed
genes that implicate alterations in neurotransmitter recep-
tors, synapse assembly and potassium channel complexes.
Recent iPSC modeling of WBS has focussed on expres-
sion in stem cells [10]. To our knowledge, our study is the
first description of WBS phenotypes in patient-derived
neurons, and is one of the first attempts to model WBS
neurological phenotypes in vitro from any species. Our
results suggest that patient-derived iPSC neurons represent
a valid alternative for studying the molecular basis of com-
plex neurological phenotypes, and provide evidence for
altered function in WBS neurons.
Results and discussion
Differentiated neurons from WBS-iPSC display neuronal
phenotypes
Previously, skin fibroblasts from a WBS patient were suc-
cessfully reprogrammed to iPSCs and characterized for
pluripotency and normal karyotype. Furthermore, these
iPSC lines were differentiated into smooth muscle cells
and the vascular disease phenotype was rescued by rapa-
mycin [11]. Kinnear et al. also confirmed that the deletion
spanned, at minimum, the sequence between FKBP6 and
CLIP2. The patient displayed characteristic cardiac ab-
normalities in infancy, and later developed neurological
phenotypes including mild global developmental delay
involving fine motor and language skills noted since 2 years
of age as well as clinical autism. However, gene testing for
FMR1 CGG repeats for Fragile X syndrome was negative
(data not shown). The patient receives occupational,
physiotherapy, speech and behavior therapy. Here we used
the same WBS iPSC lines for direct differentiation into
cortical neurons, to gain insights into the neurological
phenotype associated with WBS.
Three WBS (A, B, and I) lines and a WT iPSC line
Δ3-4-hiPS #37 [12] were directly differentiated into cortical
neurons with slight modifications from the previously pub-
lished method [13]. We performed simultaneous differenti-
ations of all 4 lines with triplicate wells tested for every
assay including Fluidigm single cell expression, immu-
nostaining, electrophysiology, and genome-wide expres-
sion profiling. In brief (Additional file 1: Figure S1A),cellular aggregates were plated to form neural rosettes
(Additional file 1: Figure S1B) that were isolated and grown
as Nestin + neural progenitor cells (Additional file 1: Figure
S1C, E). The neural progenitors were induced to form neu-
rons that were shown to have characteristic morphology
(Additional file 1: Figure S1D). After 6–8 weeks of matur-
ation in culture, neurons were immunostained and shown
to have MAP2+ dendrites and NF+ axons (Fig. 1a,b).
To characterize and determine the efficiency of the
differentiation protocol, a total of 209 single live cells
(from all 4 lines (WT and WBS A, B, I) were sorted, and
RNA extracted for quantitative reverse transcriptase
real-time PCR (qRT-PCR) analyses using a Fluidigm array
of 48 genes that mark different progenitors or neuronal
subtypes [14, 15]. This single cell analysis indicated that
the protocol was efficient in giving rise to neurons, with
80–90 % of cells expressing the mature neuronal markers
DCX, NCAM1, and MAP2 (Fig. 1c). These neurons also
expressed markers from upper and lower cortical layers,
and the subtypes of cells identified include glutamatergic
and GABA-ergic neurons (Fig. 1c,d). Similar to the findings
of Pasca et al. some promiscuous expression of progenitor
markers is detected in these cells (Fig. 1c) [14]. Neverthe-
less, the cellular morphology and neuronal marker expres-
sion were consistent with the efficient production of mixed
cortical neurons in vitro and no substantial differences in
marker expression were observed in neurons derived from
the four iPSC lines.
WBS-derived iPSC neurons show prolonged decay of action
potentials, and impaired voltage-gated K+ channel currents
To determine whether there are electrophysiological alter-
ations in WBS neurons, we obtained whole-cell patch-
clamp recordings from neurons in three WBS lines (A, B, I),
and in three WT lines – the line described above plus two
additional lines from a different unaffected control
individual. We found that the electrophysiological results
from the original WT line and the two additional WT lines
were not substantially different (not illustrated) and
therefore, the data from these three lines were pooled
as WT for the comparisons with the WBS lines. Both
WT- and WBS-iPSC neurons can generate spontaneous
(Fig. 2a) and/or evoked action potentials (Fig. 2b) that
were blocked (Additional file 2: Figure. S2A and B) by the
voltage-gated Na+ channel inhibitor tetrodotoxin (TTX;
0.5 μM). We found that the resting membrane potential
in WBS neurons was not different from those in WT-
neurons (Additional file 2: Figure S2F), but the input
resistance was higher in WBS-neurons, compared with
WT-neurons (Additional file 2: Figure S2E). Action poten-
tial characteristics of WBS-neurons and those from WT-
controls were compared in recordings from over 30 neu-
rons of each genotype. There was no significant difference
observed in rise time (Additional file 2: Figure S2D) of the
Fig. 1 (See legend on next page.)
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Fig. 1 Differentiated WBS-neurons represent all cortical layers of the brain and show normal neuronal morphology. Six week WBS A neuronal culture stained
with dendritic marker (MAP2) alone (a) and together with neurofilament (NF-axonal marker) (b). c Fluidigm single cell qRT-PCR analysis to characterize the
neurons and efficiency of the differentiation protocol. The depicted graph shows an average value of all WBS and WT neurons. d Distribution of generated
neurons for various brain cortical layers based on marker gene expression profiles
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In contrast, WBS neurons displayed deficits in action po-
tential repolarization: decay time (Fig. 2c) was significantly
longer in WBS as compared with WT-neurons. In
addition, the amplitude of the action potentials was smaller
in WBS-neurons, compared with WT-neurons (Fig. 2d).
We found a significant decrease in voltage-gated K+ cur-
rents in WBS-neurons, the channels responsible for repo-
larization [16], recorded under voltage-clamp conditions,
compared with WT-neurons (Fig. 2e). However, voltage-
gated Na+ currents in WBS neurons were not different
from those in WT neurons (Fig. 2e). Both WT- and WBS-
lines displayed spontaneous synaptic activity (Additional
file 2: Figure S2G and H). We characterized miniature ex-
citatory synaptic currents (mEPSC) and found no signifi-
cant difference in amplitude (Additional file 2: Figure S2I)
or frequency (Additional file 2: Figure S2J) between WBS-Fig. 2 WBS-neurons display prolonged decay of evoked action potentials and
were identified in WT- (Left) and WBS- (Right) neurons. b Representative trace
WT- (Left) and WBS- (Right) neurons. c-d Histograms represent average d
of WT- and WBS-neurons. “n” represents number of neurons recorded. *P < 0.
voltage-gated Na+ and K+ currents between WT- and WBS-neurons. ***P < 0.0and WT-neurons. Thus, WBS neurons appear to have nor-
mal unitary excitatory synaptic transmission and the major
electrophysiological defects are in action potential repolari-
zation and voltage-gated K+ currents.Neuronal genes in the WBS deleted region are
downregulated in WBS neurons
WBS is caused by the hemizygous deletion of multiple
genes at 7q11.23, but it is not known which of these genes
are misexpressed in WBS-neurons, or whether they con-
trol other target genes that could participate in the neur-
onal phenotypes described here. In order to determine
whether the observed electrophysiology phenotype could
be attributed to changes in gene expression, neuronal cul-
tures generated from each of the three WBS-iPSC lines
(A, B, and I) were compared to the control neuronal linedecreased voltage-gated K+ currents. a Spontaneous action potentials
s show membrane potentials responding to injection of current step in
ecay time and amplitude of evoked action potentials for all cell lines
05, **P < 0.01. e A plot showing average current–voltage relationships of
01
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these samples contained RNA pooled from 3 wells of
neurons.
To determine whether gene expression data from the
control sample (WT) is representative of other wild-type
samples, we integrated our data with expression data pro-
duced on the same platform (Illumina HumanHT12-v4)
from wild-type iPSC-derived neurons in Stein et al. [17]
samples Gage-1, Gage-2, Gage-3, Gage-4, Gage-5, Gage-6
(Additional file 3: Figure S3). Visual inspection of hierarch-
ical clustering revealed that our control sample clustered
with control samples from the Gage lab and not with WBSFig. 3 Genes within the hemizygous WBS deletion show reduced expression
described in Additional file 5: Table S1. a A bar graph of the neuronally expre
WT-iPSC neurons, as determined through microarray analysis. Genes with no
signal ≥100). All expressed genes that were confirmed to be deleted through
corresponds with half the expression of the controls as indicated by the dash
the array results. Expression was normalized to HMBS, and an averaged fold c
control. All five genes were expressed at less than half the level of expressionsamples. Thus, our control sample was representative of
the gene expression pattern in wild-type iPSC-derived neu-
rons for downstream analyses.
Examination of genes from within the WBS commonly
deleted region at 7q11.23 showed that most genes were
expressed in iPSC-derived neurons, and were downregu-
lated in the WBS neurons compared to WT neurons
(Fig. 3a). Those genes that did not meet the expression
threshold on the array (Detection P-value <0.01) were
excluded from further analysis. To validate the changes
detected in the array, qRT-PCR was used to determine the
expression levels of five neuronally expressed genesin differentiated iPSC neurons. The primers used for validation are
ssed genes at 7q11.23 show the log2 fold change expression of WBS- vs.
change in expression were below the array detection threshold (average
MLPA were found to be downregulated [11]. A log2 fold change of -1
ed line. b qRT-PCR of five neuronally expressed genes was used to verify
hange of each WBS neuronal line (n = 3) is presented relative to the WT
in WT iPSC-derived neurons. Data are shown as mean ± SEM
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region, four of which have been linked to the neurological
profile [18–23]. All five genes were expressed below 50 %
of the level of expression in the WT neurons, indicating
that there was no transcriptional compensation for the loss
of one allele (Fig. 3b).
Global gene expression is altered in WBS neurons
We chose 25 neuronally-expressed genes for validation
using qRT-PCR. All were shown to have altered expres-
sion in the same direction as seen on the array (Fig. 4a).
To investigate possible mechanisms of voltage-gated potas-
sium channel dysfunction, as revealed by electrophysiology,Fig. 4 qRT-PCR Validation and gene set enrichment analysis. a Twenty-five di
Expression values from each WBS iPSC neuronal line (n = 3) were normalized
WT control. All 25 genes showed altered expression in the same direction as
change in expression values from the array, with red indicating lower and
as mean ± SEM. b Log2 fold change of the top 15 downregulated genes
the microarray. c Enrichment Plots of the two most highly enriched gene sets
change, are shown in the corresponding tables (Additional file 6: Table S2, Add
S5). d Enriched synaptic gene sets are highly interconnected. Enrichment Map
sets (FDR <0.1) as a network of interconnected nodes. The size of each node c
normalized enrichment score, with a darker green corresponding to stronger n
the edges between nodes corresponds to the number of genes the gene sets
was comprised of gene sets governing synaptic function, is shown (46 out of a
Figure S4we examined expression of genes in the voltage-gated
potassium channel complex gene set (Gene Ontology gene
set GO:0008076). We found that the vast majority of them
were down-regulated (Fig 4b), including qRT-PCR validated
reductions in KCNIP4, KCNMB1, KCNMB2, KCNMA1 in
addition to WBS-deletion region gene STX1A and SNAP25
(Fig. 4b). To determine which functions were perturbed in
WBS neurons, we performed a continuous gene set enrich-
ment analysis [24] with gene sets from the gene ontology
database. We ranked differentially expressed probes by the
t-statistic and tested which gene sets were overrepresented
among top-ranked (i.e. upregulated in WBS) or bottom-
ranked (i.e. downregulated in WBS) genes (Additional filefferentially expressed genes were chosen for validation using qRT-PCR.
to HMBS and TBP, and are presented as average fold change relative to
identified on the array; the corresponding heatmap shows the log2 fold
blue indicating higher expression in WBS samples. Data are shown
in the voltage-gated potassium channel complex (GO:0008076) from
in the dataset. The top 10 genes in each gene set, ranked by absolute fold
itional file 7: Table S3, Additional file 8: Table S4 and Additional file 9: Table
[25] in Cytoscape was used to visualize overlap between enriched gene
orresponds to the size of the gene set. The node color corresponds to the
egative enrichment (lower expression in WBS relative to WT). The size of
share in common. The largest interconnected network of nodes, which
total 136 nodes). The full enrichment map is shown in Additional file 4:
Khattak et al. Molecular Brain  (2015) 8:77 Page 7 of 116: Table S2, Additional file 7: Table S3, Additional file 8:
Table S4 and Additional file 9: Table S5). Out of 5370 gene
sets, 136 were enriched in WBS samples at a false discovery
rate of 0.1. Strikingly, all 136 gene sets had negative
enrichment scores, suggesting that they are enriched
among bottom-ranking genes. The top negatively enriched
gene sets were ‘neurotransmitter receptor activity’
(GO:0030594) and ‘synapse assembly’ (GO:0007416)
(Fig. 4c).
To discover functional themes connecting the 136 gene
sets, we visualized their overlap using the Enrichment Map
plugin in Cytoscape (Additional file 4: Figure S4). Here,
gene sets are visualized as a network of interconnected
nodes based on the number of genes they have in common
[25]. The largest connected network was found for gene
sets governing synaptic function (46 gene sets total, Fig. 4d).
This analysis suggested that ion channels, presynaptic
function and GABA receptor function were particularly
affected in WBS neurons (Fig. 4a). In addition, we found a
network of 7 gene sets governing extracellular matrix func-
tion (ECM), with several gene sets showing particularly
strong enrichment (Additional file 4: Figure S4), which
may be analogous to the known role of ELN insufficiency
in the cardiovascular WBS phenotype.
The affected gene sets we discovered in WBS neurons,
in part, match those found in a recent gene expression
study on WBS iPSCs and NPCs by Adamo et al. [10].
In common, we found enrichment of gene sets relating
to synapse assembly, synaptic transmission and ECM
organization. In addition, we also found two networks
of gene sets governing heart and renal development
(Additional file 4: Figure S4) also observed by Adamo
et al. [10] and known to be perturbed in WBS.
Of those transcripts identified as belonging to signifi-
cantly enriched gene sets, many encoded ion channels.
Using qRT-PCR, we validated the upregulation of glu-
tamate receptor subunit GRIK1 and the downregulation
of GABA receptor subunit GABRA3. Dysregulation of
either gene would suggest perturbations in neuronal sig-
nalling and function; interestingly, decreased expression
of GABRA3 has been found in brains of patients with
autism spectrum disorder [26, 27] and a truncating mu-
tation has been found in a male with ASD [28].
In addition, we observed downregulation of transcripts
for voltage-gated Na+ and K+ channels in WBS neurons.
Downregulation of SCN3B and SCN2A Na+ channel
subunits may explain the observed smaller amplitude of ac-
tion potentials (Fig. 2d). The prolonged decay time observed
in WBS neurons could be caused by altered function of
voltage-gated K+ channels (Fig. 2e). This could be attributed
to the observed downregulation of one, or a combination, of
KCNIP4 (voltage-gated potassium channel gene), KCNMB1,
KCNMB2 and KCNMA1 (calcium-activated potassium
channel genes). However, we cannot exclude the possibilitythat the decrease of voltage-gated K+ current was due to the
altered expression of other proteins directly and/or indir-
ectly regulating K+ channels.
Voltage-gated K+ channels are broadly expressed in vari-
ous types of neurons in the central nervous system and
play critical roles in regulating neuronal excitability. Muta-
tions of the proteins mediating the voltage-gated K+ cur-
rents can cause cellular dysfunction and diseases, and the
channels have been used as therapeutic targets [16]. De-
creased expression of gene KCTD7, a progressive myoclo-
nus epilepsy gene encoding voltage-gated K+ channel
tetramerisation domain containing 7, has been reported in
WBS patients [29]. Additional reports have indicated that
WBS patients suffer from progressive hearing loss of un-
known cause [30–32]. Mutations in the proteins mediat-
ing voltage-gated KCNQ4 channel, a subtype of KV7/
KCNQ/M channels, can lead to progressive hearing loss
[33]. Prolongation of action potential repolarization in our
present study, due to the decrease in voltage-gated K+ cur-
rents in WBS neurons, may perturb temporal and spatial
integration for input at the somata, and thus alter the
neuronal firing output.
At synapses, we found that unitary mEPSCs are not
altered in WBS neurons (Additional file 2: Figure S2I,J) indi-
cating that quantal size is not different. Moreover, mEPSC
frequency was not altered in WBS neurons indicating that
action potential-independent transmitter release is not
affected. However, the prolongation of action potential repo-
larization which we observed (Fig. 2) may facilitate Ca2+
influx and thereby Ca2+-dependent transmitter release [34].
Thus, action potential-dependent transmission might be
increased at WBS neuronal by increasing quantal content.
The gene sets downregulated in WBS neurons extend our
understanding of WBS-specific alterations in neuronal gene
expression. There is significant overlap among these gene
sets with those reported in the gene expression study on
WBS iPSCs and NPCs by Adamo et al. [10]. Common gene
sets belong to synapse assembly, synaptic transmission,
ECM organization and two networks of gene sets governing
heart and renal function that are known to be perturbed in
WBS (Additional file 4: Figure S4). The significance of these
heart and renal networks to neuronal function is currently
unclear and we cannot rule out the possibility that their ap-
pearance is due to the presence of contaminating disease-
relevant cell types in our differentiations. Novel to WBS
neuronal function, we have found a profound reduction of
transcript levels of voltage-gated potassium channel genes
(Fig 4b), as well as neurotransmitter receptor genes (Fig 4c).
These changes may affect electrophysiological properties, as
well as alter neurotransmission in WBS neurons. The pro-
longation of action potential repolarization in WBS neurons
in our experiments provides support for the former. Taken
together, our results extend the findings of Adamo et al. [10]
to include abnormalities in neuronal gene expression.
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Our findings show that WBS neurons derived from patient
iPSCs have dysregulated expression of genes including
those encoding many ion channels that lie outside the
WBS deletion. The expression profile is consistent with the
observed electrophysiological defects with prolonged action
potential repolarization resulting from a deficit in voltage-
activated K+ currents. The observed alterations in K+ cur-
rents and action potential repolarization are predicted to
dramatically alter integration, output and action potential-
dependent transmission in networks of WBS neurons. Such
altered cellular and network functioning may be a critical
determinant underlying deficits in visuospatial construction
and cognitive ability in patients with WBS.
Methods
WBS iPS cell line derivation and directed neuronal
differentiation
The derivation and pluripotency characterization of WBS
iPS cell lines has been reported previously [11]. Neuronal
differentiations were carried out as described previously [13]
but with minor modifications, which are described here in
detail. Briefly, WBS (A, B and I hiPSC lines) and WT iPSC
line (Δ3-4-hiPS #37) [12] were dissociated to form cellular
aggregates and cultured in suspension on low cluster plates
with media changes everyday in Knockout DMEM contain-
ing knockout serum replacement, GlutaMAX-1, non-
essential amino acids, 2-marcaptoethanol and supplemented
with bFGF (10 ng/ml), SB431542 (10 μM) and Dorsomor-
phin (2 μM). The media was switched to neural induction
media on day 4 containing DMEM-F12, N2, non-essential
amino acids, Heparin (2 μg/ml), bFGF (10 ng/ml),
SB431542 (10 μM) and Dorsomorphin (2 μM). On day 6,
the cellular aggregates were seeded onto polyornithin/lam-
inin coated dishes in neural induction media without
SB431542. The cells were fed with fresh media every second
day till day 17. On the 17th day of differentiation, the neural
rosettes were manually dissected and plated onto polyor-
nithin and laminin coated plates to obtain secondary ro-
settes. The media was changed every second day with
neural induction media without SB431542 and Dorsomor-
phin. On day 25 of differentiation, the secondary rosettes
were manually harvested from the plates and spun down for
2 mins at 600 rpm (69 g) in a swing bucket tabletop centri-
fuge. The cell pellet was resuspended in 1 ml acutase and in-
cubated for 10 min at room temperature. 1 ml of neural
precursor media (DMEM F12, N2, B27 + RA, laminin, non-
essential amino acids, heparin, bFGF) was added and cells
were triturated gently to break apart the rosettes and obtain
single cells. Cells were pelleted at 600 rpm (69 g) for 2 mins,
resuspend in 2 ml of neural precursor media, and plated
onto polyornithin/laminin coated plates. For neuronal differ-
entiations, glass cover slips were coated with polyornithin
and laminin and placed into 24 well plates. The neuralprecursor cells were plated at a density of 5 × 104 cells per
well in complete neural differentiation media (Neurobasal,
N2, non-essential amino acids, BDNF (10 ng/ml), GDNF
(10 ng/ml), IGF-1 (10 ng/ml), B27 (without RA), cAMP
(1 μM), Ascorbic acid (200 ng/ml), Laminin (1 μg/ml). The
media was changed every second day for 6–8 weeks. The
protocol was repeated at least three independent times start-
ing from hES/iPS cells. The generation and description of
two additional human WT iPSC lines from a different un-
affected control individual, and their neuronal differentiation
was described in Zhang et al. (submitted).
Characterization of neurons using single cell qRT-PCR and
immunostaining
Three wells of each WT, WBS A, WBS B, and WBS I neur-
onal cultures (after 6 weeks of maturation) were dissociated
with acutase and sorted based on propidium-iodide into 96-
well qRT-PCR plates. The pre-amplification mix and
primers for individual gene expression analysis and Fluidigm
Dynamic Arrays were performed as described previously
[14]. Fluidigm data analysis was performed using the R-
Statistical analysis software (https://cran.r-project.org/), for
which scripts are available upon request. Cells were identi-
fied based on expression of both GAPDH and 18S. A cell
was defined as expressing a given marker if it exhibited de-
tectable cDNA of the appropriate melting temperature dur-
ing the course of a 35 cycle Fluidigm run. Cells expressing
NCAM, MAP2 and DCX were classed as neurons. Further
classification by cortical layer and neurotransmitter type was
defined as follows: ETV1+ or FOXP1+, lower layer; ETV1-
FOXP1- and any of CUX1+ SATB2+ CTIP2+ REELIN+,
upper layer; GAD65+ GAD67+ VGAT+ CALB1+ CALB2+
or PVALB+, GABAergic; CAMK2+ VGLUT1+ VGLUT2+
or VGLUT3+, glutamatergic.
Immunostaining of neuronal cultures were done as de-
scribed previously [12]. Antibodies against phosphorylated
neurofilaments (SMI-31R) Covance (1:1000 dilution), and
MAP2 (AB5622) Millipore (1:2000 dilution) were used to
perform the immunostaining.
Electrophysiology
Human iPSC-derived neurons after 6 weeks of culture
were used for whole-cell patch-clamp recordings at room
temperature as previously reported for mouse neurons
[35]. An Axopatch 1-D amplifier (Molecular Devices) was
used and the signals were low-pass filtered at 2 kHz.
Micropipette electrodes were prepared from borosilicate
capillary glass (World Precision Instruments, Inc., USA),
using a P-87 pipette puller (Sutter Instrument Co., USA).
The intracellular recording solutions consisted of (in
mM): 144 K+-gluconate, 10 KCl, 10 HEPES, 2 EGTA,
and 2 Mg2+-ATP, pH adjusted to 7.2 with KOH. The
external recording solutions were composed of (in mM):
140 NaCl, 5.4 KCl, 1 MgCl2, 15 HEPES, 2 CaCl2, and 10
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ionic currents, under whole-cell voltage-clamp conditions,
were elicited by depolarizing neuronal membrane poten-
tials to a series of potentials from -60 mV to 60 mV for
400 ms, and voltage-gated K+ currents were calculated at
the end of the depolarizing step. To evoke action poten-
tials in iPS cell-derived neurons, a series of current steps
from -5 pA to +50 pA, under whole-cell current-clamp
conditions, were injected every 10 s, and action potential
parameters were based on analysis of the first evoked
action potentials.
Whole-cell voltage-clamp recording was performed
on iPSC-derived neurons at the membrane potential
of -60 mV for recording mEPSC with the external record-
ing solutions (in mM, pH 7.35): 140 NaCl, 5.4 KCl, 1.3
CaCl2, 15 HEPES, 25 glucose, 0.0005 tetrodotoxin, 0.001
glycine; 0.01 bicuculline, and 0.01 strychnine. The internal
solutions contained (in mM, pH 7.2): 137 CsF, 1.5 CsCl, 10
HEPES, 10 BAPTA, 4 Mg2+-ATP. The recordings were
made at room temperature, and the mEPSC activities were
analyzed off-line using Mini Analysis Program (Synaptosoft
Inc, NJ, USA). Statistical analysis was performed using
Student’s t-test. Data were displayed as mean ± SEM.
Microarray analysis using Illumina HT-12 v4 Beadchip
Three wells of each WT, WBS A, WBS B, and WBS I
differentiated neurons were pooled to extract RNA. 1 μg
of RNA from each iPSC derived neuronal sample; WT,
WBS A, WBS B, and WBS I; was submitted to The Centre
for Applied Genomics at the Hospital for Sick Children,
Toronto, for analysis on the Illumina HT-12 v4 Beadchip
array (Illumina, San Diego, CA), which targets over 47,000
probes. Raw intensity values were exported and analyzed
using the R limma package. To determine whether gene
expression data from our control sample (WT) is repre-
sentative of other wild-type samples, we integrated our
data with expression data produced on the same platform
(Illumina HumanHT12-v4) from wild-type iPSC-derived
neurons in Stein et al. [16] samples Gage-1, Gage-2, Gage-
3, Gage-4, Gage-5, Gage-6. Supplementary data containing
background-corrected unnormalized probe intensity
values was downloaded from the gene expression omnibus
(GEO Accession: GSE57595). This data was merged with
unnormalized, background-corrected (nec function in
limma [36]) values from our dataset. The merged dataset
was log2-transformed, quantile normalized and batch-
corrected using the R package ComBat.
To compare gene expression between our WT sample
and the three WBS samples, the probe IDs were converted
to nuIDs to improve annotation consistency. The neqc
function [36] was used for background correction and
quantile normalization. The data were log2 transformed
and probes with detection p-values >0.01 in all samples
were removed for downstream analyses (22134 probesremaining out of 47320). To perform gene set enrichment
analysis, all probes were ranked by the t-statistic produced
by an empirical Bayes statistics (eBayes) of the resulting
linear model (lmfit) of the microarray. We used gene sets
from the Gene Ontology: Biological Process database and
filtered out datasets that were overly large (>900 genes) or
overly small (<15 genes). Gene sets enriched at a false
discovery rate (FDR) of <0.1 were used to construct an
Enrichment Map [25] in Cytoscape [37] to visualize gene
set interconnectedness and identify perturbed cellular
functions.
RNA extraction, cDNA synthesis, and qRT-PCR analysis
500 ng of RNA was converted to cDNA using Superscript
III Reverse Transcriptase according to manufacturer
guidelines (Life Technologies, Burlington, Canada). The
samples were diluted 1:100, and quantitative real-time
PCR (qRT-PCR) was used to validate hemizygosity of
the WBS deletion region, and differentially expressed
genes (Power SYBR Green PCR Master Mix, Life Tech-
nologies). The primers used for validation are described in
Additional file 5: Table S1. qRT-PCR analysis was carried
out on aViiA 7 Real-Time PCR System (Life Technologies),
and expression values were determined by interpolating a
standard curve derived from human brain total RNA
(Clontech, Mountain View, CA) as previously described
[38]. Expression values from each of the three WBS iPSC
neuronal lines were normalized to the housekeeping genes
HMBS and TBP, and are presented as fold change relative
to the WTcontrol.
Additional files
Additional file 1: Figure S1. Neuronal differentiation protocol and marker
characterization. Outline of the differentiation protocol (A). Brightfield images
of (day 17) neural rosettes (B), Neural precursor cells six days post
plating (passage 1) from rosettes (C) and 4 week old Neurons (D)
derived from WBS-iPS cells. Immunostaining of WBS-iPS cell derived
(passage 10) neural precursor cells with Nestin (neural stem cell
marker) and Dapi (blue-nuclear stain) (E). Scale bars: 100 μm (B,E),
200 μm (C,D). (TIF 33780 kb)
Additional file 2: Figure S2. Action potentials are sensitive to
tetrodotoxin. Both spontaneous (A) and evoked (B) action potentials
were blocked by the application of TTX (0.5 μM) in WT-neurons. Bar
graphs showing the half-duration (C) and rise time (D) of evoked action
potentials in WT-neurons compared with WBS-neurons. Bar graphs
showing average input resistance (E) and resting membrane potential
(F) in WT-neurons compared with WBS-neurons, *P < 0.05. Spontaneous
mEPSC activities were recorded in WT- (G) and WBS- (H) neurons. Histograms
showing amplitude (I) and frequency (J) of mEPSC in WT-neurons compared
with WBS-neurons. (TIF 600 kb)
Additional file 3: Figure S3. Hierarchical clustering plots of wild type
neurons. Hierarchical clustering by differentially expressed genes using
integrated microarray data. Microarray data from our study (WT and WBS
samples: A, B, I) was integrated with expression data from wild-type
iPSC-derived neurons run on the same Illumina HumanHT-12 v4
microarray from [17] (Samples Gage-1, Gage-2, Gage-3, Gage-4, Gage-5,
Gage-6). Unnormalized data was downloaded from GEO (accession number
GSE57595), merged with our unnormalized data, log2-transformed, quantile
Khattak et al. Molecular Brain  (2015) 8:77 Page 10 of 11normalized, and corrected for batch effect using ComBat. Hierarchical
clustering of differentially expressed genes shows that the WT sample
from our study is representative of other wild-type samples. (TIF 54 kb)
Additional file 4: Figure S4. Enrichment Map of all 136 enriched gene
sets in the microarray data sets at FDR <0.1. Enrichment Map [25] in
Cytoscape was used to visualize overlap between enriched gene sets
(FDR <0.1) as a network of interconnected nodes. The size of each node
corresponds to the size of the gene set. The node color corresponds to
the normalized enrichment score, with a darker green corresponding to
stronger negative enrichment (lower expression in WBS relative to WT).
The size of the edges between nodes corresponds to the number of genes
the gene sets share in common. (TIF 1360 kb)
Additional file 5: Table S1. Primers used for quantitative real-time PCR
validation of differentially expressed genes. (XLSX 54 kb)
Additional file 6: Table S2. Table of negatively enriched gene sets.
(XLSB 195 kb)
Additional file 7: Table S3. Table of positively enriched gene sets.
(XLSB 188 kb)
Additional file 8: Table S4. Detailed tables for the top 20 negatively
and positively enriched gene sets, sorted in order of decreasing absolute
fold change. (XLS 308 kb)
Additional file 9: Table S5. Table of differentially expressed genes used
for ranking genes for GSEA. (XLS 4906 kb)Abbreviations
ADHD: Attention deficit, hyperactivity disorder; ECM: Extracellular matrix;
FDR: False-discovery rate; iPSC: Induced pluripotent stem cell; mEPSC: miniature
excitatory postsynaptic current; qRT-PCR: quantitative reverse transcriptase
real-time PCR; WBS: Williams-Beuren Syndrome; WT: Wild-type; TTX: Tetrodotoxin.Competing interests
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